FOLLOWUS
Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results
- Chinese Journal of Integrative Medicine Vol. 18, Issue 6, Pages: 417-422(2012)
- Affiliations：
Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University,Beijing,China
- Author bio：
- Funds：
DOI：10.1007/s11655-012-1113-z
CLC：Published：2012，
Published Online：11 April 2012，
Scan for full text
Feng, H., Chen, Xm., Li, Cy. et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results., Chin. J. Integr. Med. 18, 417–422 (2012). https://doi.org/10.1007/s11655-012-1113-z
Hai Feng, Xue-ming Chen, Chen-yu Li, et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results. [J]. Chinese Journal of Integrative Medicine 18(6):417-422(2012)
Feng, H., Chen, Xm., Li, Cy. et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results., Chin. J. Integr. Med. 18, 417–422 (2012). https://doi.org/10.1007/s11655-012-1113-z DOI：
Hai Feng, Xue-ming Chen, Chen-yu Li, et al. Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection (舒血宁注射液) infusion for chronic lower extremity ischemia: 3-year results. [J]. Chinese Journal of Integrative Medicine 18(6):417-422(2012) DOI： 10.1007/s11655-012-1113-z.
摘要
To investigate the efficacy and safety of combined common femoral artery (CFA) endarterectomy with superficial femoral artery (SFA) stenting plus Shuxuening Injection (舒血宁注射液) infusion in patients with complex multifocal arterial steno-obstructive lesions of the lower extremities. From March 2006 to March 2011
104 lower limbs in 96 patients with multilevel peripheral arterial steno-occlusive disease
involving SFA as well as CFA and deep femoral artery (DFA) orifice
were treated by combined surgical with endovascular therapy
such as SFA stenting as an adjunct to CFA endarterectomy and patch angioplasty with the great saphenous vein. Before the end of the operation
20 mL of Shuxuening Injection was infused through the catheter located in the treated artery. Technical and hemodynamic success
as well as primary and primary-assisted patency
was determined according to the Society for Vascular Surgery Guidelines. During follow-up
clinical status assessment
ankle-brachial index (ABI) test
and duplex Doppler ultrasound were administered every 6 months
and computed tomography angiography or magnetic resonance angiography was performed at 12
24
and 36 months after discharge. All patients underwent successful combined CFA endarterectomy with SFA stenting treatment. The average ABI after the combination treatment increased from pretreatment of 0.32±0.21 to 0.82±0.24 (P<0.01). No perioperative death and major limb amputations occurred. The mean duration of follow-up for 104 limbs from 96 patients was 1
180 days (range
196–2
064 days). During follow-up
5 patients died due to myocardial infarction
cerebral infarction
or pneumonia
and 5 patients were lost to follow-up. There were 21 cases (21.4%) of restenosis
with 15 that occurred in-stent and 6 near the distal end of the stent. A total of 18 (18.3%) reinterventions were performed
including 6 balloon angioplasty
8 restenting procedures
2 bypass surgeries
and 2 major limb amputations. The primary patency rates were 92.2%
76.8%
and 61.3% at 12
24
and 36 months
respectively
while the primary-assisted patency rates were 94.4%
83.2%
and 75.6% at 12
24
and 36 months
respectively. The combined CFA endarterectomy with SFA stenting plus Shuxuening Injection infusion appears to offer a safe
less invasive
and effective treatment option to patients with chronic lower extremity ischemia due to complex multifocal peripheral artery disease.
Abstract
To investigate the efficacy and safety of combined common femoral artery (CFA) endarterectomy with superficial femoral artery (SFA) stenting plus Shuxuening Injection (舒血宁注射液) infusion in patients with complex multifocal arterial steno-obstructive lesions of the lower extremities. From March 2006 to March 2011
104 lower limbs in 96 patients with multilevel peripheral arterial steno-occlusive disease
involving SFA as well as CFA and deep femoral artery (DFA) orifice
were treated by combined surgical with endovascular therapy
such as SFA stenting as an adjunct to CFA endarterectomy and patch angioplasty with the great saphenous vein. Before the end of the operation
20 mL of Shuxuening Injection was infused through the catheter located in the treated artery. Technical and hemodynamic success
as well as primary and primary-assisted patency
was determined according to the Society for Vascular Surgery Guidelines. During follow-up
clinical status assessment
ankle-brachial index (ABI) test
and duplex Doppler ultrasound were administered every 6 months
and computed tomography angiography or magnetic resonance angiography was performed at 12
24
and 36 months after discharge. All patients underwent successful combined CFA endarterectomy with SFA stenting treatment. The average ABI after the combination treatment increased from pretreatment of 0.32±0.21 to 0.82±0.24 (P<0.01). No perioperative death and major limb amputations occurred. The mean duration of follow-up for 104 limbs from 96 patients was 1
180 days (range
196–2
064 days). During follow-up
5 patients died due to myocardial infarction
cerebral infarction
or pneumonia
and 5 patients were lost to follow-up. There were 21 cases (21.4%) of restenosis
with 15 that occurred in-stent and 6 near the distal end of the stent. A total of 18 (18.3%) reinterventions were performed
including 6 balloon angioplasty
8 restenting procedures
2 bypass surgeries
and 2 major limb amputations. The primary patency rates were 92.2%
76.8%
and 61.3% at 12
24
and 36 months
respectively
while the primary-assisted patency rates were 94.4%
83.2%
and 75.6% at 12
24
and 36 months
respectively. The combined CFA endarterectomy with SFA stenting plus Shuxuening Injection infusion appears to offer a safe
less invasive
and effective treatment option to patients with chronic lower extremity ischemia due to complex multifocal peripheral artery disease.
关键词
chronic lower extremity ischemiaendarterectomystentingangioplastyShuxuening Injectionhybrid technique
Keywords
chronic lower extremity ischemiaendarterectomystentingangioplastyShuxuening Injectionhybrid technique
references
Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radio 1999;10:1219–1228.
Ballard JL, Sparks SR, Taylor FC, Bergan JJ, Smith DC, Bunt TJ, et al. Complications of iliac artery stent deployment. J Vasc Surg 1996;24:545–555.
Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular disease. Cardiovasc Drug Rev 2004;22:309–319.
Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992;34:352–358
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes. TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg 2007;45(Suppl):S5–67.
Cotroneo AR, Jezzi R, Marano G, Fonio P, Nessi F, Gandini G, et al. Hybrid therapy in patients with complex peripheral multifocal steno-obstructive vascular disease: two-year results. Cardiovasc Interv Radio 2007;30:355–361.
Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. New Engl J Med 2006;354:1879–1888.
Mewissen MW. Sel f -expanding ni t inol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radio 2004;7:2–5.
Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516–521.
Nishibe T, Kondo Y, Nishibe M, Muto A, Dardik A, Nishibe T. Stent placement of femoropopliteal arterial occlusive disease in high-risk patients: preliminary results. Surg Today 2009;39:21–26.
Myers KA. Reporting standards and statistics for evaluating intervention. Cardiovasc Surg 1995;3:455–461.
Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 2010;147:268–274.
Nelson PR, Powell RJ, Schermerhorn ML, Fillinger MF, Zwolak RM, Walsh DB, et al. Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg 2002;35:1107–1113.
Mousa A, Abdel-Hamid M, Ewida A, Saad M, Sahrabi A. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic extremity ischemia: preliminary result. Intern Soc Vasc Surg 2010;18:71–76.
Edwards WH Jr, Martin RS III, Jenkins JM, Edwards WH Sr, Mulherin JL Jr. Primary graft infections. J Vasc Surg 1987;6:235–239.
Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg 1991;13:751–753.
Kemmel RM, Murphy RX, Chowdary RP. Optimal management of inguinal vascular graft infections. Ann Plast Surg 1994;32:623–629.
Spence MT, David AW, Eugene ML, Jonathan SL. Outcomes in the management of vascular prosthetic graft infections confined to groin: a reappraisal. Ann Vasc Surg 1996;10:117–122.
Bao YM, Liu AH, Zhang ZX, Li Y, Wang XY. Effects of Ginkgo biloba extract 50 preconditioning on contents of inflammation-related cytokines in myocardium of rats with ischemia-reperfusion injury. J Chin Integr Med (Chin) 2010;8:373–378.
Yuan LP, Chen ZW, Li F, Dong LY, Chen FH. Protective effect of total flavones of rhododendra on ischemic myocardial injury in rabbits. Am J Chin Med 2006;34:483–492.
Saleem S, Zhuang H, Biswal S, Christen Y, Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008;12:3389–3396.
Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000;108:276–281.
Peters H, Kieser M, Holscher U. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication-a placebo-controlled, double-blind multicenter trial. Vasa 1998;27:106–110.
Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357–362.
Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J Vasc Surg 2010;52:232–236.
Reed AB. Endovascular as an open adjunct: use of hybrid endovascular treatment in the SFA. Semin Vasc Surg 2008;21:200–203.
Sikkink CI, Reijnen MM, Zeebregts CI. The creation of the optimal dedicated endovascular suite. Eur J Endovasc Surg 2008;35:198–204.
Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffeto JD. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg 2008;196:634–640.
0
Views
94
Downloads
2
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
